Atlas Trials

A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia

Clinical trial NCT05479591 · WITHDRAWN

Trial details

NCT number
NCT05479591
Sponsor
Novo Nordisk A/S
Status
WITHDRAWN
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2022-07-30
Primary completion
2023-04-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.